Literature DB >> 3349028

Purification and characterization of human salivary peroxidase.

B Mansson-Rahemtulla1, F Rahemtulla, D C Baldone, K M Pruitt, A Hjerpe.   

Abstract

Human salivary peroxidase (SPO) has been purified to homogeneity by subjecting human parotid saliva to immunoaffinity, cation exchange, and affinity chromatography. These procedures resulted in a 992-fold purification of the enzyme. When purified SPO was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), three Coomassie stainable bands were apparent, all of which stained positive for enzyme activity. The apparent molecular weights of the three bands were 78,000, 80,000, and 280,000 as analyzed by SDS-PAGE. Reduction with 2-mercaptoethanol resulted in a decreased mobility of these bands, and enzyme activity could no longer be detected on the gels. The SPO preparation had the characteristic peroxidase heme spectrum in the range 405-420 nm. The ratio between the absorbance of the Soret band (412 nm) and the absorbance at 280 nm was 0.81. The enzyme activity was inhibited by the classical peroxidase inhibitors cyanide and azide. Salivary peroxidase is similar to bovine lactoperoxidase (LPO) in amino acid composition, in ultraviolet and visible spectrum, in reaction with cyanide, in susceptibility to 2-mercaptoethanol inactivation, and in thermal stability. The two enzymes differ in carbohydrate composition and content. SPO contains 4.6% and LPO 7% total neutral sugars. The ratio of glucosamine to galactosamine is 2:1 in SPO and 3:1 in LPO. SPO contains mannose, fucose, and galactose in a molar ratio of 1.5:1.5:1.0, while the ratio was 14.9:0.5:1.0 in LPO. Glucose was present in both preparations in minor amounts. The concentration of azide required for 50% inhibition of enzyme activity was 20-fold greater for LPO than for SPO.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349028     DOI: 10.1021/bi00401a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  The lactoperoxidase system links anion transport to host defense in cystic fibrosis.

Authors:  Gregory E Conner; Corinne Wijkstrom-Frei; Scott H Randell; Vania E Fernandez; Matthias Salathe
Journal:  FEBS Lett       Date:  2006-12-19       Impact factor: 4.124

2.  Characterization of sheep lacrimal-gland peroxidase and its major physiological electron donor.

Authors:  A Mazumdar; R Chatterjee; S Adak; A Ghosh; C Mondal; R K Banerjee
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

3.  Molecular heterogeneity and alternative splicing of human lactoperoxidase.

Authors:  Miryam A Fragoso; Aliza Torbati; Nevis Fregien; Gregory E Conner
Journal:  Arch Biochem Biophys       Date:  2008-11-24       Impact factor: 4.013

4.  Expression and characterization of bovine lactoperoxidase by recombinant vaccinia virus.

Authors:  Tetsuya Tanaka; Xuenan Xuan; Asato Kojima; Ikuo Igarashi; Kozo Fujisaki; Kei-Ichi Shimazaki
Journal:  Cytotechnology       Date:  2009-02-12       Impact factor: 2.058

5.  Identification and characterization of VPO1, a new animal heme-containing peroxidase.

Authors:  Guangjie Cheng; John C Salerno; Zehong Cao; Patrick J Pagano; J David Lambeth
Journal:  Free Radic Biol Med       Date:  2008-09-23       Impact factor: 7.376

6.  Thiocyanate, a plausible physiological electron donor of gastric peroxidase.

Authors:  D Das; P K De; R K Banerjee
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

7.  Influence of a model human defensive peroxidase system on oral streptococcal antagonism.

Authors:  Michael T Ashby; Jens Kreth; Muthu Soundarajan; Laure Sita Sivuilu
Journal:  Microbiology (Reading)       Date:  2009-08-14       Impact factor: 2.777

8.  Monolayer culture of rat parotid acinar cells without basement membrane substrates.

Authors:  C S Kiser; F Rahemtulla; B Månsson-Rahemtulla
Journal:  In Vitro Cell Dev Biol       Date:  1990-09

9.  Effects of the common cold and intranasal fluticasone propionate treatment on mucosal host defense assessed by human saliva.

Authors:  M Lenander-Lumikari; T Puhakka; M J Mäkelä; P Vilja; O Ruuskanen; J Tenovuo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-06

10.  Candida albicans susceptibility to lactoperoxidase-generated hypoiodite.

Authors:  Mohamed Ahariz; Philippe Courtois
Journal:  Clin Cosmet Investig Dent       Date:  2010-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.